CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
By J. Brenchley, T. Schacker, Laura E. Ruff, D. Price, Jodie H. Taylor, G. Beilman, P. Nguyen, A. Khoruts, Matthew Larson, A. Haase and 1 more. Journal of Experimental Medicine, 2004
1,978 citations recorded by the source corpus.
The mechanisms underlying CD4+ T cell depletion in human immunodeficiency virus (HIV) infection are not well understood. Comparative studies of lymphoid tissues, where the vast majority of T cells reside, and peripheral blood can potentially illuminate the pathogenesis of HIV-associated disease. Here, we studied the effect of HIV infection on the activation and depletion of defined subsets of CD4+ and CD8+ T cells in the blood, gastrointestinal (GI) tract, and lymph node (LN). We also measured HIV-specific T cell frequencies in LNs and blood, and LN collagen deposition to define architectural changes associated with chronic inflammation. The major findings to emerge are the following: the GI tract has the most substantial CD4+ T cell depletion at all stages of HIV disease; this depletion occurs preferentially within CCR5+ CD4+ T cells; HIV-associated immune activation results in abnormal accumulation of effector-type T cells within LNs; HIV-specific T cells in LNs do not account for all effector T cells; and T cell activation in LNs is associated with abnormal collagen deposition. Taken together, these findings define the nature and extent of CD4+ T cell depletion in lymphoid tissue and point to mechanisms of profound depletion of specific T cell subsets related to elimination of CCR5+ CD4+ T cell targets and disruption of T cell homeostasis that accompanies chronic immune activation.
Subfields: Immunology, Virology
View Paper: https://www.semanticscholar.org/paper/a3349a48194250ca3b7e7821cf27291aac000ce0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Virology
- Daniel C. Douek
- Steven G. Deeks
- Mario Roederer
- R. Koup
- V. Appay
- D. Sauce
- Beatrice H. Hahn
- John C. Mingers
Citations in the corpus
- The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection (2009, background): “Virus then spreads via the blood to other lymphoid tissue, especially that in the gut (2).”
- Dendritic-cell interactions with HIV: infection and viral dissemination (2006, background): “Also, because CD4 + T-cell populations in the gastrointestinal tract suffer the most marked depletion in both the acute and the chronic stage of HIV infectio”
- Immune activation and inflammation in HIV‐1 infection: causes and consequences (2008, background): “It is noteworthy that mucosal CD4+ T cells consist predominantly of memory CD4+ T cells which express the HIV co-receptor CCR5 and present relatively activated status [3–5]; they are therefore ideal targets for the virus.”
- Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. (2008, background): “Most HIV-infected individuals experience a dramatic and early loss of CD4+ T cells from the lamina propria of the gastrointestinal tract [43–45], physical disruption of the mucosal barrier [46, 47], and mucosal repair gene expression defects [48].”
- Emerging Concepts in the Immunopathogenesis of AIDS (2009, background): “Inflammatory damage to lymphoid tissues may underlie thymic dysfunction (17, 18) and TGF-β-mediated fibrosis of lymph nodes (19, 20), which are, in turn, associated with abnormal retention of effector-type T cells (21) and poor immune reconstitution with ART (22).”
- Zinc finger nuclease-mediated CCR5 knockout hematopoietic stem cell transplantation controls HIV-1 in vivo (2010, neutral): “Of particular interest was the presence of a large population of human CD4+CCR5+ cells in the intestine, since T cells in the gut-associated lymphoid tissue (GALT) represent a significant population that is targeted by both HIV-1 in humans and SIV in primates (28– 34).”